Business Context and Reporting Period
This Form 6-K filing by EUDA Health Holdings Ltd (EUDA) covers the month of August 2025. The report details a new financing arrangement entered into on August 1, 2025, with an institutional investor.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial data relates to a new convertible promissory note facility:
- Total Facility Size: Up to $10,000,000 in aggregate convertible promissory notes.
- Initial Advance: $1,000,000 (First Advance) to be issued upon the first closing.
- Conversion Terms: Notes convert to ordinary shares at 85% of the trading price on the conversion date.
- Early Default Terms: If the closing bid price falls below $2.00 for five consecutive days and the Company fails to pay principal and fees within 10 business days, the conversion discount increases to 70%.
- Share Reservation: 5,000,000 ordinary shares reserved for full conversion.
- Put Option: The Company may request the Purchaser to buy a Note at 90% of the principal amount; the Purchaser has five business days to decline or accept.
Material Changes
The material change reported is the execution of the Convertible Promissory Note Purchase Agreement. This represents a new source of potential capital and a potential future dilution event for existing shareholders, contingent on the conversion of the notes.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on operations, or specific risk factors beyond the terms of the agreement. Key contingencies include:
- Early Default Trigger: A stock price below $2.00 for five consecutive days combined with a payment default triggers a more dilutive conversion rate (70% discount).
- Put Request Risk: The Company's ability to force the sale of notes to the investor is subject to the investor's right to decline within five business days.
- Regulatory Status: The transaction is part of a Registration Statement on Form F-3 (File No. 333-282723) declared effective on November 4, 2024.
Investor Verification Checklist
- Verify the current trading price of EUDA's ordinary shares relative to the $2.00 Early Default threshold.
- Confirm the closing date and receipt of the $1,000,000 First Advance.
- Review the full text of the Purchase Agreement (Exhibit 1.1) for additional covenants or fees not summarized here.
- Assess the potential dilution impact of converting up to $10,000,000 of notes at the 85% discount rate.
- Check for any subsequent filings regarding the exercise of the Put Request or additional advances.